Disclaimer: This is sponsored content. All opinions and views are of the advertiser and do not reflect the same of WFTS. Advertiser: BeOne Medicines Ltd.
A diagnosis of chronic lymphocytic leukemia (CLL) can be overwhelming, but advances in cancer research, including targeted therapies, have paved the way for more precise treatments.
CLL is one of the most common blood cancers in adults, and because its progression varies from person to person, choosing a tailored treatment plan is crucial.
We're joined by Lynne, who shares her personal journey with CLL, and Dr. Nakhle Saba, director of lymphoid malignancy and CAR T-cell therapy at Our Lady of the Lake Cancer Institute. He provides insight into the latest treatment approaches and why informed decision-making is so essential for those facing this disease.
For more information, visit Brukinsa.com.
